QS trades 19.4% below Wall Street's consensus target of $9.60.
Last 12 months price action with 12-month analyst target path
The base valuation assumes QS achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 11 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, QuantumScape Corporation (QS) has a Wall Street consensus price target of $9.60, based on estimates from 11 covering analysts. With the stock currently trading at $8.04, this represents a potential upside of +19.4%. The company has a market capitalization of $4.93B.
Analyst price targets range from a low of $8.30 to a high of $12.00, representing a 39% spread in expectations. The median target of $8.50 differs from the mean, suggesting potential outlier estimates.
The current analyst consensus rating is Hold, with 0 analysts rating the stock as a Buy or Strong Buy,8 rating it Hold, and 3 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, QS trades at a trailing P/E of -10.6x. Analysts expect EPS to grow +3.3% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
SESSES AI Corporation | $358M | $1.11 | $1.40 | +26.1% | Hold | — | 4 |
SLDPSolid Power, Inc. | $623648 | $2.87 | — | — | Buy | — | 5 |
MVSTMicrovast Holdings, Inc. | $430M | $1.29 | $4.80 | +272.1% | Buy | 11.7x | 6 |
ENVXEnovix Corporation | $1.5B | $7.08 | $11.67 | +64.8% | Buy | — | 16 |
AMPXAmprius Technologies, Inc. | $2.3B | $16.17 | $19.60 | +21.2% | Buy | — | 12 |
CBATCBAK Energy Technology, Inc. | $61M | $0.68 | — | — | — | — | — |
ALBAlbemarle Corporation | $18.9B | $160.35 | $209.75 | +30.8% | Hold | 13.2x | 45 |
LACLithium Americas Corp. | $976M | $4.37 | $7.00 | +60.2% | Hold | — | 15 |
MPMP Materials Corp. | $10.8B | $60.88 | $83.00 | +36.3% | Buy | 262.2x | 12 |
PCRXPacira BioSciences, Inc. | $878M | $22.33 | $32.00 | +43.3% | Hold | 7.8x | 36 |
Quick answers to the most common questions about buying QS stock.
QuantumScape Corporation (QS) has a consensus 12-month price target of $9.6, implying 19.4% upside from $8.04. The 11 analysts covering QS see moderate appreciation potential.
QS has a consensus rating of "Hold" based on 11 Wall Street analysts. The rating breakdown is leaning bearish, with 3 Sell/Strong Sell ratings. The consensus 12-month price target of $9.6 implies 19.4% upside from current levels.
QS's current price is $8.04 with a consensus target of $9.6 (19.4% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $12 for QS, while the most conservative target is $8.3. The consensus of $9.6 represents the median expectation. These targets typically reflect 12-month expectations.
QS is moderately covered, with 11 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 8 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month QS stock forecast based on 11 Wall Street analysts shows a consensus price target of $9.6, with estimates ranging from $8.3 (bear case) to $12 (bull case). The median consensus rating is "Hold".
Wall Street analysts are optimistic on QS, with a "Hold" consensus rating and $9.6 price target (19.4% upside). 0 of 11 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
QS analyst price targets range from $8.3 to $12, a 39% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $9.6 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.